High Speed Analysis of Pharmaceutical Impurities in Compliance with European Pharmacopoeia Using Nexera-i MT

C10G-E056 Solutions for Pharmaceutical Analysis Application Notebook First Edition: March, 2018 © Shimadzu Corporation, 2018 Solutions for Pharmaceutical Analysis Index Application Notebook Basic Research and Drug Discovery Development of a Phospholipid Profiling Method Using Triple Quadrupole LC-MS/MS This article shows…

LAAN-A-LC-E299 Application News No. L524 High Performance Liquid Chromatography High-Speed Analysis of Pramipexole following the Draft Guidance of International Harmonization of Pharmacopoeias In recent years, ultra-high performance liquid chromatography (hereinafter, UHPLC) has been widely adopted in the pharmaceutical field to…

LAAN-A-LC-E298 Application News Analysis of Irbesartan Using an Integrated LC System - NexeraTM-i MT Y. Osaka „ System Suitability Test Table 1 shows the analytical conditions used for a system suitability test in the quantitative determination of irbesartan and amlodipine…

LAAN-A-LC-E295 Application News No. L520 High Performance Liquid Chromatography Analysis of Montelukast Sodium Using Prominence-i and Nexera-i MT Montelukast sodium is used as a therapeutic drug for treating bronchial asthma and allergic rhinitis, and is listed in the 17th edition…